Table 1 Summary of the studies deducing synergy of nanoparticles and antibiotic as antimicrobial and anti-biofilm agent
Reference | Type of nanoparticle | Antibiotic | Species | Report year | |
---|---|---|---|---|---|
Gram-positive | Gram-negative | ||||
52 | Ag nanoparticle | Ampicillin, chloramphenicol, kanamycin | Enterococcus faecium, Staphylococcus aureus | Pseudomonas aeruginosa, Escherichia coli | 2012 |
24 | Ag nanoparticle | Gentamicin, ampicillin, ofloxacin, vancomycin | – | Escherichia coli | 2013 |
10 | Ag nanoparticle | Ampicillin, vancomycin | Staphylococcus aureus, Streptococcus pneumoniae | Pseudomonas aeruginosa, Shigella flexneri | 2014 |
11 | Cu nanoparticle | Ciprofloxacin | Staphylococcus aureus | Pseudomonas aeruginosa | 2015 |
51 | Ag nanoparticle | Amikacin, kanamycin, oxytetracycline, streptomycin | Staphylococcus aureus | Pseudomonas aeruginosa, Escherichia coli | 2016 |
9 | Cu nanoparticle, ZnO nanoparticle | Ceftriaxone, ceftazidime, gentamicin | Enterococcus faecalis, Staphylococcus aureus | Pseudomonas aeruginosa, Escherichia coli, Shigella flexneri, Klebsiella pneumoniae | 2016 |